ArticleJournal of clinical medicine2024

Safety and Tolerability of SGLT2 Inhibitors in Cardiac Amyloidosis-A Clinical Feasibility Study.

Maximilian J Steinhardt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.